» Articles » PMID: 27862553

Intravoxel Incoherent Motion Diffusion-weighted MRI During Chemoradiation Therapy to Characterize and Monitor Treatment Response in Human Papillomavirus Head and Neck Squamous Cell Carcinoma

Overview
Date 2016 Nov 19
PMID 27862553
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Characterize and monitor treatment response in human papillomavirus (HPV) head and neck squamous cell carcinoma (HNSCC) using intra-treatment (intra-TX) imaging metrics derived from intravoxel incoherent motion (IVIM) diffusion-weighted magnetic resonance imaging (DW-MRI).

Materials And Methods: Thirty-four (30 HPV positive [+] and 4 HPV negative [-]) HNSCC patients underwent a total of 136 MRI including multi-b value DW-MRI (pretreatment [pre-TX] and intra-TX weeks 1, 2, and 3) at 3.0 Tesla. All patients were treated with chemo-radiation therapy. Monoexponential (yielding apparent diffusion coefficient [ADC]) and bi-exponential (yielding perfusion fraction [f], diffusion [D], and pseudo-diffusion [D*] coefficients) fits were performed on a region of interest and voxel-by-voxel basis, on metastatic neck nodes. Response was assessed using RECISTv1.1. The relative percentage change in D, f, and D* between the pre- and intra-TX weeks were used for hierarchical clustering. A Wilcoxon rank-sum test was performed to assess the difference in metrics within and between the complete response (CR) and non-CR groups.

Results: The delta (Δ) change in volume (V) for the CR group differed significantly (P = 0.016) from the non-CR group, while not for V and V (P > 0.05). The mean increase in ΔD for the CR group was significantly higher (P = 0.017) than the non-CR group. ADC and D showed an increasing trend at each intra-TX week when compared with pre-TX in CR group (P < 0.003). Hierarchical clustering demonstrated the existence of clusters in HPV + patients.

Conclusion: After appropriate validation in a larger population, these IVIM imaging metrics may be useful for individualized treatment in HNSCC patients.

Level Of Evidence: 2 J. Magn. Reson. Imaging 2017;45:1013-1023.

Citing Articles

Reduced-distortion diffusion weighted imaging for head and neck radiotherapy.

Aliotta E, Paudyal R, Dresner A, Shukla-Dave A, Lee N, Cervino L Phys Imaging Radiat Oncol. 2024; 32:100653.

PMID: 39399877 PMC: 11466654. DOI: 10.1016/j.phro.2024.100653.


Combination of intravoxel incoherent motion histogram parameters and clinical characteristics for predicting response to neoadjuvant chemoradiation in patients with locally advanced rectal cancer.

Yang A, Lin L, Xu H, Chen X, Zhou P Abdom Radiol (NY). 2024; .

PMID: 39395044 DOI: 10.1007/s00261-024-04629-6.


Relating pre-treatment non-Gaussian intravoxel incoherent motion diffusion-weighted imaging to human papillomavirus status and response in oropharyngeal carcinoma.

Sijtsema N, Lauwers I, Verduijn G, Hoogeman M, Poot D, Hernandez-Tamames J Phys Imaging Radiat Oncol. 2024; 30:100574.

PMID: 38633282 PMC: 11021835. DOI: 10.1016/j.phro.2024.100574.


Auto-segmentation of neck nodal metastases using self-distilled masked image transformer on longitudinal MR images.

Paudyal R, Jiang J, Han J, Diplas B, Riaz N, Hatzoglou V BJR Artif Intell. 2024; 1(1):ubae004.

PMID: 38476956 PMC: 10928808. DOI: 10.1093/bjrai/ubae004.


The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance.

McDonald B, Dal Bello R, Fuller C, Balermpas P Semin Radiat Oncol. 2023; 34(1):69-83.

PMID: 38105096 PMC: 11372437. DOI: 10.1016/j.semradonc.2023.10.003.


References
1.
Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009; 15(3):986-94. PMC: 2673914. DOI: 10.1158/1078-0432.CCR-08-1287. View

2.
Jansen J, Koutcher J, Shukla-Dave A . Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis. 2010; 13(2):149-60. PMC: 2912423. DOI: 10.1007/s10456-010-9167-z. View

3.
Koh D, Scurr E, Collins D, Kanber B, Norman A, Leach M . Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol. 2007; 188(4):1001-8. DOI: 10.2214/AJR.06.0601. View

4.
OSullivan B, Huang S, Siu L, Waldron J, Zhao H, Perez-Ordonez B . Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013; 31(5):543-50. DOI: 10.1200/JCO.2012.44.0164. View

5.
Chenevert T, McKeever P, Ross B . Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res. 1998; 3(9):1457-66. View